Searching across hundreds of databases
FLT3-L-dependent classical dendritic cells (cDCs) recruit anti-tumor and tumor-protecting lymphocytes. We evaluate cancer growth in mice with low, normal, or high levels of cDCs. Paradoxically, both low or high numbers of cDCs improve survival in mice with melanoma. In low cDC context, tumors are restrained by the adaptive immune system through influx of effector T cells and depletion of Tregs and NK cells. High cDC numbers favor the innate anti-tumor response, with massive recruitment of activated NK cells, despite high Treg infiltration. Anti CTLA-4 but not anti PD-1 therapy synergizes with FLT3-L therapy in the cDCHi but not in the cDCLo context. A combination of cDC boost and Treg depletion dramatically improves survival of tumor-bearing mice. Transcriptomic data confirm the paradoxical effect of cDC levels on survival in several human tumor types. cDCHi-TregLo state in such patients predicts best survival. Modulating cDC numbers via FLT3 signaling may have therapeutic potential in human cancer.
Pubmed ID: 38118422 RIS Download
Publication data is provided by the National Library of Medicine ® and PubMed ®. Data is retrieved from PubMed ® on a weekly schedule. For terms and conditions see the National Library of Medicine Terms and Conditions.
Global nonprofit biological resource center (BRC) and research organization that provides biological products, technical services and educational programs to private industry, government and academic organizations. Its mission is to acquire, authenticate, preserve, develop and distribute biological materials, information, technology, intellectual property and standards for the advancement and application of scientific knowledge. The primary purpose of ATCC is to use its resources and experience as a BRC to become the world leader in standard biological reference materials management, intellectual property resource management and translational research as applied to biomaterial development, standardization and certification. ATCC characterizes cell lines, bacteria, viruses, fungi and protozoa, as well as develops and evaluates assays and techniques for validating research resources and preserving and distributing biological materials to the public and private sector research communities.
View all literature mentionsNetwork of ftp and web servers around world that store identical, up to date, versions of code and documentation for R. Package archive network for R programming language.
View all literature mentionsTHIS RESOURCE IS NO LONGER IN SERVICE. Documented on May 5,2022.Tool that predicts interactions between transcription factors and their regulated genes from binding motifs. Understanding vertebrate development requires unraveling the cis-regulatory architecture of gene regulation. PRISM provides accurate genome-wide computational predictions of transcription factor binding sites for the human and mouse genomes, and integrates the predictions with GREAT to provide functional biological context. Together, accurate computational binding site prediction and GREAT produce for each transcription factor: 1. putative binding sites, 2. putative target genes, 3. putative biological roles of the transcription factor, and 4. putative cis-regulatory elements through which the factor regulates each target in each functional role.
View all literature mentionsSoftware repository for R packages related to analysis and comprehension of high throughput genomic data. Uses separate set of commands for installation of packages. Software project based on R programming language that provides tools for analysis and comprehension of high throughput genomic data.
View all literature mentionsSoftware for single-cell flow cytometry analysis. Its functions include management, display, manipulation, analysis and publication of the data stream produced by flow and mass cytometers.
View all literature mentionsAn Organization portal, Antibody supplier, Service resource,
View all literature mentionsAmerican chemical, life science and biotechnology company owned by Merck KGaA. Merger of Sigma Chemical Company and Aldrich Chemical Company. Provides organic and inorganic chemicals, building blocks, reagents, advanced materials and stable isotopes for chemical synthesis, medicinal chemistry and materials science, antibiotics, buffers, carbohydrates, enzymes, forensic tools, hematology and histology, nucleotides, proteins, peptides, amino acids and their derivatives.
View all literature mentionsSoftware package for the analysis of gene expression microarray data, especially the use of linear models for analyzing designed experiments and the assessment of differential expression.
View all literature mentionsA unified data repository of the National Cancer Institute (NCI)'s Genomic Data Commons (GDC) that enables data sharing across cancer genomic studies in support of precision medicine. The GDC supports several cancer genome programs at the NCI Center for Cancer Genomics (CCG), including The Cancer Genome Atlas (TCGA), Therapeutically Applicable Research to Generate Effective Treatments (TARGET), and the Cancer Genome Characterization Initiative (CGCI). The GDC Data Portal provides a platform for efficiently querying and downloading high quality and complete data. The GDC also provides a GDC Data Transfer Tool and a GDC API for programmatic access.
View all literature mentionsSoftware package for differential gene expression analysis based on the negative binomial distribution. Used for analyzing RNA-seq data for differential analysis of count data, using shrinkage estimation for dispersions and fold changes to improve stability and interpretability of estimates.
View all literature mentionsThis monoclonal targets ROR gamma (t)
View all literature mentionsThis monoclonal targets CD279 (PD-1)
View all literature mentionsThis monoclonal targets CD335 (NKp46)
View all literature mentionsThis monoclonal targets NK-1.1
View all literature mentionsThis monoclonal targets NK1.1
View all literature mentionsThis monoclonal targets NK1.1
View all literature mentionsThis monoclonal targets I-A/I-E
View all literature mentionsThis monoclonal targets NK1.1
View all literature mentionsThis monoclonal targets MHC Class II (I-A/I-E)
View all literature mentionsThis monoclonal targets Ly-6G
View all literature mentionsThis monoclonal targets Mouse Ly-6G
View all literature mentionsThis monoclonal targets Ly-6A/E
View all literature mentionsThis monoclonal targets Mouse Ly-6A / E
View all literature mentionsThis monoclonal targets Ki-67
View all literature mentionsThis monoclonal targets IL-17
View all literature mentionsThis monoclonal targets IL-10
View all literature mentionsThis isotype control targets Rat IgG2a kappa
View all literature mentionsThis isotype control targets not applicable
View all literature mentionsThis monoclonal targets IFN-gamma
View all literature mentionsThis monoclonal targets FOXP3
View all literature mentionsThis monoclonal targets F4/80
View all literature mentionsThis monoclonal targets F4/80
View all literature mentionsThis monoclonal targets CD326 (Ep-CAM)
View all literature mentionsThis unknown targets Cross-Reactive EOMES
View all literature mentionsThis monoclonal targets CD209a
View all literature mentionsThis monoclonal targets CD152 (CTLA-4)
View all literature mentionsThis monoclonal targets CD206
View all literature mentionsThis monoclonal targets CD135 (Flt3)
View all literature mentionsThis monoclonal targets CD135 (Flt3)
View all literature mentionsThis monoclonal targets CD103 (Integrin αIEL)
View all literature mentionsThis monoclonal targets CD86 (B7-2)
View all literature mentionsThis monoclonal targets CD69
View all literature mentionsThis monoclonal targets CD62L
View all literature mentionsThis monoclonal targets CD45
View all literature mentionsThis monoclonal targets CD44 (Pgp-1, Ly-24)
View all literature mentionsThis monoclonal targets CD40
View all literature mentionsThis monoclonal targets CD27
View all literature mentionsThis monoclonal targets CD19
View all literature mentionsThis monoclonal targets CD16/32
View all literature mentionsThis monoclonal targets CD11c
View all literature mentionsThis monoclonal targets CD11c
View all literature mentionsThis monoclonal targets CD11b
View all literature mentionsThis monoclonal targets CD11b
View all literature mentionsThis monoclonal targets CD8a
View all literature mentionsThis monoclonal targets CD3
View all literature mentionsThis monoclonal targets CD25
View all literature mentionsThis unknown targets Asialo-GM1
View all literature mentionsMus musculus with name B6.129S(C)-Batf3tm1Kmm/J from IMSR.
View all literature mentionsMus musculus with name B6(Cg)-Zbtb46tm1(HBEGF)Mnz/J from IMSR.
View all literature mentionsMus musculus with name C57BL/6-Flt3ltm1Imx/TacMmjax from MMRRC.
View all literature mentions
Mus musculus with name NOD.Cg-Prkdcscid Il2rg
Mus musculus with name C57BL/6J from IMSR.
View all literature mentionsMus musculus with name C57BL/6JRj from IMSR.
View all literature mentionsCell line YUMM1.7 is a Cancer cell line with a species of origin Mus musculus (Mouse)
View all literature mentionsCell line MC-38 is a Cancer cell line with a species of origin Mus musculus
View all literature mentionsCell line B16-FLT3L is a Cancer cell line with a species of origin Mus musculus (Mouse)
View all literature mentionsCell line B16-F10 is a Cancer cell line with a species of origin Mus musculus (Mouse)
View all literature mentionsThe SciCrunch Infrastructure was developed as a cooperative data platform to be used by diverse communities in making data more FAIR.
scicrunch.org
